Breaking News Instant updates and real-time market news.

AAPL

Apple

$162.71

6.3 (4.03%)

, MA

MasterCard

$168.19

2.99 (1.81%)

07:35
02/13/18
02/13
07:35
02/13/18
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Monday in Apple (AAPL), Mastercard (MA), Yandex (YNDX), Under Armour (UA), Hecla Mining (HL), Spectrum Brands (SPB), and (ADT).

AAPL

Apple

$162.71

6.3 (4.03%)

MA

MasterCard

$168.19

2.99 (1.81%)

YNDX

Yandex

$36.50

0.61 (1.70%)

UA

Under Armour

$13.18

0.72 (5.78%)

HL

Hecla Mining

$3.75

0.26 (7.45%)

SPB

Spectrum Brands

$102.01

-5.22 (-4.87%)

ADT

ADT Inc.

$12.68

0.04 (0.32%)

  • 13

    Feb

  • 13

    Feb

  • 15

    Feb

  • 15

    Feb

  • 19

    Feb

  • 23

    Feb

  • 07

    Mar

  • 15

    Mar

AAPL Apple
$162.71

6.3 (4.03%)

02/12/18
WELS
02/12/18
NO CHANGE
Target $195
WELS
Market Perform
Apple iPhone X was highest selling model, says Wells Fargo
Wells Fargo analyst Aaron Rakers notes that IDC has published its detailed estimates for smartphone shipments for the December quarter. The analyst thinks it is important to point out that, like Apple, IDC reports shipments on a sell-in less basis, with iPhone X shipments in the December quarter at 26.9M, which accounts for 35% of total shipments in Q4. Despite less than a full quarter of availability, iPhone X was the highest selling model in the September and December quarters, accounting for 22% of total shipments, he adds. Rakers reiterates a Market Perform rating and $195 price target on the shares.
02/08/18
BERN
02/08/18
NO CHANGE
Target $125
BERN
Market Perform
NXP Semiconductors results likely to bring Qualcomm deal price to a head, says Bernstein
Bernstein analyst Stacy Rasgon notes that NXP Semiconductors' (NXPI) Q4 results were "very strong," and wonders a bit how much upside might have been Apple (AAPL)-related given SCD and SII dynamics given obvious weakness in the latter's supply chain. The analyst believes NXP Semiconductors' strong results are likely to bring the Qualcomm (QCOM) deal price to a head, but could also make it easier for management to justify a higher price, and it does not appear challenging to justify higher levels even with the shares at a discount to the industry. Rasgon reiterates a Market Perform rating and $125 price target on NXP Semiconductors' shares.
02/06/18
MKMP
02/06/18
NO CHANGE
Target $54
MKMP
Buy
Cirrus Logic price target lowered to $54 from $74 at MKM Partners
MKM Partners analyst Ruben Roy lowered his price target on Cirrus Logic (CRUS) to $54 after a Q3 earnings miss attributed to unexpected weakness in smartphone demand that began to materialize in late December. Roy also notes the Q4 outlook well below consensus, suggesting that the handset demand remains weak. The analyst keeps his Buy rating on Cirrus Logic longer term however, based on the company's ability to benefit from content gain opportunities at Apple (AAPL) and new design opportunities at Android manufacturers as well as ongoing proliferation of audio and voice technologies.
02/08/18
BOFA
02/08/18
NO CHANGE
Target $220
BOFA
Buy
Apple 'a name to own' in volatile markets, says BofA/Merrill
BofA Merrill Lynch analyst Wamsi Mohan calls Apple "a name to own" in times of market volatility, citing its low leverage, high cash balance, attractive valuation and opportunities for future growth. The analyst, who already models a 10% dividend increase in 2018 and expects Apple to announce a new authorization in the April timeframe that could be higher than its typical annual $30B-$50B, reiterates a Buy rating and $220 price target on Apple shares.
MA MasterCard
$168.19

2.99 (1.81%)

02/02/18
02/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. MasterCard (MA) upgraded to Buy from Hold at Argus with analyst Stephen Biggar saying the stock should trade above its historical average earnings multiple, with effective tax rate of 20% seen below 27% in 2017 as well as continued strong purchase volumes and growth in cross-border volumes and processed transactions. 2. Tableau (DATA) upgraded to Hold from Sell at Maxim with analyst Nehal Chokshi citing normalized bookings accelerating to 26% growth in the fourth quarter and sees normalized sales productivity stabilizing at about a 33% level. 3. Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale with analyst Warren Ackerman saying fourth quarter results were "solid" as emerging markets are rebounding strongly and the worst is over in North America. 4. Huntington Ingalls (HII) upgraded to Outperform from Market Perform at Cowen with analyst Gautam Khanna saying the shares are "excessively discounted" relative to the large cap defense peer average. 5. Sherwin-Williams (SHW) upgraded to Buy from Neutral at Seaport Global with analyst Michael Harrison saying the Valspar deal adds another layer of potential growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/02/18
BMOC
02/02/18
NO CHANGE
Target $206
BMOC
Outperform
MasterCard price target raised to $206 from $174 at BMO Capital
BMO Capital analyst Paulo Ribeiro raised his price target on MasterCard to $206 after the company's Q4 earnings beat that was driven by "across-the-board strength in payment volumes". Ribeiro contends that MasterCard's outlook was also conservative and expects the stock to benefit from strong intra-quarter metrics and expected buybacks while the company is investing in growth. The analyst keeps his Outperform rating on MasterCard.
02/02/18
ARGS
02/02/18
UPGRADE
Target $200
ARGS
Buy
MasterCard upgraded to Buy at Argus on continued strength in purchase volume
As reported earlier, Argus analyst Stephen Biggar upgraded MasterCard to Buy from Hold with a price target of $200 after the company's Q4 earnings beat. The analyst says the stock should trade above its historical average earnings multiple, with effective tax rate of 20% seen below 27% in 2017 as well as continued strong purchase volumes and growth in cross-border volumes and processed transactions.
02/02/18
RBCM
02/02/18
NO CHANGE
Target $209
RBCM
Outperform
MasterCard price target raised to $209 from $180 at RBC Capital
RBC Capital analyst Daniel Perlin raised his price target on MasterCard to $209 and kept his Outperform rating. Perlin says the company's Q4 earnings were better than expected, and the outlook for 2018 appears to be "very positive" despite the accounting changes and tax reform "noise".
YNDX Yandex
$36.50

0.61 (1.70%)

11/02/17
VTBC
11/02/17
DOWNGRADE
VTBC
Hold
Yandex downgraded to Hold from Buy at VTB Capital
01/16/18
DBAB
01/16/18
NO CHANGE
Target $50
DBAB
Buy
Yandex price target raised to $50 from $42 at Deutsche Bank
Deutsche Bank analyst Lloyd Walmsley raised his price target for Yandex to $50 saying he sees "meaningful upside" to the shares over the next three years as the ride share business scales and the company expands Uber Eats in Russia. Yandex Taxi alone could grow to $50 per share by 2023 in a "blue sky scenario," Walmsley tells investors in a research note. Today he values the Yandex pro forma ride share entity with Uber at $12 per share. The analyst reiterates a Buy rating on Yandex.
11/13/17
VTBC
11/13/17
UPGRADE
Target $40
VTBC
Buy
Follow-up: Yandex upgraded to Buy at VTB Capital
As previously reported, VTB Capital upgraded Yandex to Buy from Hold with a $40 price target. Analyst Vladimir Bespalov believes Yandex's ongoing investments into online advertising, taxi, and e-commerce are not fully reflected in valuation and views the recent correction in shares as an attractive entry-point.
11/13/17
VTBC
11/13/17
UPGRADE
VTBC
Buy
Yandex upgraded to Buy from Hold at VTB Capital
UA Under Armour
$13.18

0.72 (5.78%)

02/09/18
JEFF
02/09/18
NO CHANGE
JEFF
Buy
Under Armour discounting down dramatically in last three months, says Jefferies
Jefferies analyst Randal Konik says his firms' February webscrapes point to better traction at Under Armour (UAA) with discounts down in each of the last three months. The company's discounts decreased from 70% in November to 23% in February, down more than 30% year-over-year this month, Konik tells investors in a research note. Further, a survey of 200 footwear retailers shows the Under Armour HOVR Phantom is building momentum, the analyst adds. In addition, the survey shows Nike (NKE) is gaining back share from adidas (ADDYY) in running across the U.S. and Europe. In Basketball, Nike continues to dominate, while Under Armour's Curry 4 is resonating well with consumers, Konik writes. The analyst has a Buy rating on Under Armour and Hold rating on Nike.
01/16/18
01/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Neutral at Macquarie with analyst Laurent Vasilescu citing weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. 2. Verizon (VZ) downgraded to Neutral from Buy at MoffettNathanson. 3. Lockheed Martin (LMT) and Rockwell Collins (COL) were downgraded to Market Perform from Outperform at Wells Fargo. 4. Spirit Airlines (SAVE) downgraded to Hold from Buy at Stifel with analyst Joseph DeNardi saying he believes Spirit will benefit this year from an improving demand and revenue environment, but that its higher revenue risk relative to potential competitive responses to its expected capacity growth is not fully reflected in the stock at current levels. 5. Finisar (FNSR) downgraded to Sell from Neutral at Goldman Sachs with analyst Doug Clark saying risks of oversupply and competition are heating up in the optical component landscape. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/16/18
01/16/18
DOWNGRADE
Target $8

Underperform
Under Armour downgraded to Underperform at Macquarie
As previously reported, Macquarie analyst Laurent Vasilescu downgraded Under Armour to Underperform from Neutral and cut its price target to $8 from $10. Vasilescu lowered his FY18 EBIT to $25M from $85M to reflect weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. The analyst expects the credit agreement will need to be amended and expects Under Armour will need a capital raise if gross margins and SG&A continue to deteriorate.
02/06/18
JEFF
02/06/18
NO CHANGE
Target $72
JEFF
Hold
Jefferies sees too much management turnover at lululemon
The level of management turnover at lululemon during "this critical juncture in the company's growth trajectory gives us some pause," Jefferies analyst Randal Konik tells investors in a research note following the resignation of CEO Laurent Potdevin. The analyst sees better opportunities elsewhere, namely in shares of Under Armour (UAA), given lululemon's "high" valuation high and "less plentiful" margin opportunity going forward. He maintains a Hold rating on lululemon with a $72 price target.
HL Hecla Mining
$3.75

0.26 (7.45%)

12/04/17
CANT
12/04/17
INITIATION
Target $5
CANT
Overweight
Hecla Mining initiated with a Buy at Cantor Fitzgerald
Cantor Fitzgerald analyst Mike Kozak started Hecla Mining with a Buy rating and $5 price target. The analyst sees near term momentum from resolution of the strike at Lucky Friday and refinancing of the company's long-term debt. He believes both can happen in the first half of 2018.
11/30/17
RILY
11/30/17
UPGRADE
Target $5
RILY
Buy
Hecla Mining upgraded to Buy from Neutral at B. Riley FBR
B. Riley FBR analyst Lucas Pipes upgraded Hecla Mining to Buy with a $5 price target citing an attractive valuation and the company's Q3 performance.
11/17/17
BMOC
11/17/17
INITIATION
Target $4.75
BMOC
Market Perform
Hecla Mining initiated with a Market Perform at BMO Capital
BMO Capital analyst Ryan Thompson initiated Hecla Mining with a Market Perform rating and a $4.75 price target. Thompson says the company offers some of the "longest reserve lives" in the precious metal mining group, but valuation of price relative to Net Present Value is steep while the company's balance sheet is "weak".
11/14/17
11/14/17
UPGRADE
Target $5.25

Buy
Hecla Mining upgraded to Buy after post-earnings pullback at Canaccord
As previously reported, Canaccord analyst Dalton Baretto upgraded Hecla Mining (HL) to Buy from Hold, stating that he does not believe the selloff in the stock since the company's Q3 report is justified. Hecla reported strong production, but lower than expected revenue due to timing of shipments, which he expects to reverse next quarter, Baretto tells investors. The analyst, who also views the post-earnings selloff in Pan American Silver (PAAS) as overdone, now has Buy ratings on both miners. He has a $5.25 price target on Hecla and a $23 price target on Pan American.
SPB Spectrum Brands
$102.01

-5.22 (-4.87%)

01/16/18
RAJA
01/16/18
NO CHANGE
Target $140
RAJA
Outperform
Spectrum Brands price target raised to $140 from $124 at Raymond James
01/17/18
KEYB
01/17/18
NO CHANGE
Target $140
KEYB
Overweight
Spectrum Brands price target raised to $140 from $130 at KeyBanc
KeyBanc analyst Jason Gere raised his price target for Spectrum Brands (SPR) to $140 from $130 following the announcement that Energizer (ENR) is buying the company's Global Battery and Lighting segment for $2B, which he sees as a win for both sides. The analyst reiterates an Overweight rating on Spectrum Brands' shares.
01/17/18
KEYB
01/17/18
NO CHANGE
Target $64
KEYB
Overweight
Energizer price target raised to $64 from $55 at KeyBanc
KeyBanc analyst Jason Gere raised his price target for Energizer (ENR) to $64 from $55 following the announcement that the company is buying Spectrum Brands' (SPR) Global Battery and Lighting segment for $2B, which he sees as a win for both sides. The analyst reiterates an Overweight rating on Energizer's shares.
01/17/18
RHCO
01/17/18
NO CHANGE
Target $70
RHCO
Buy
Energizer price target raised to $70 from $60 at SunTrust
SunTrust analyst William B. Chappell raised his price target on Energizer (ENR) to $70 following the announcement that the company is buying Spectrum Brands' (SPR) Global Battery and Lighting segment for $2B. The analyst contends that there is upside from the forecast synergy target in the deal, that those synergies can be attained faster than the 3 year outlook, and that anti-trust issues can be avoided as Energizer can present the deal to regulators as an expansion into the private label segment of the market. Chappell keeps his Buy rating on Energizer.
ADT ADT Inc.
$12.68

0.04 (0.32%)

02/13/18
FBCO
02/13/18
INITIATION
Target $14
FBCO
Neutral
ADT Inc. initiated with a Neutral at Credit Suisse
Credit Suisse analyst Anjaneya Singh started ADT Inc. with a Neutral rating and $14 price target. The analyst is less optimistic on the company's growth acceleration given "slow-moving industry penetration rates" and the potential threat of new entrants.
02/13/18
DBAB
02/13/18
INITIATION
Target $16
DBAB
Buy
ADT Inc. initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Kevin McVeigh started ADT Inc. with a Buy rating and $16 price target. The analyst expects multiple expansion as the market becomes more comfortable with the company's execution and cash flow.
02/13/18
SBSH
02/13/18
INITIATION
Target $16
SBSH
Buy
ADT Inc. initiated with a Buy at Citi
Citi analyst Peter Christiansen started ADT Inc. with a Buy rating and $16 price target. The company's operational turnaround and business-to-many model is underappreciated, the analyst tells investors in a research note.
02/13/18
BOFA
02/13/18
INITIATION
Target $16
BOFA
Buy
ADT Inc. initiated with a Buy at BofA/Merrill
BofA/Merrill analyst David Ridley-Lane initiated ADT Inc. with a Buy and $16 price target saying shares trade at a sizeable valuation gap versus peers with strong free cash flow growth that has a long runway.

TODAY'S FREE FLY STORIES

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

12:07
06/23/18
06/23
12:07
06/23/18
12:07
Hot Stocks
Array BioPharma announces updated results from Phase 3 BEACON CRC trial »

Array BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

DDAIF

Daimler AG

$0.00

(0.00%)

, BMWYY

BMW

$0.00

(0.00%)

11:42
06/23/18
06/23
11:42
06/23/18
11:42
Periodicals
EU to respond to any U.S. auto tariffs, Reuters reports »

The EU will respond to…

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$67.60

-0.2 (-0.29%)

, GE

General Electric

$13.05

0.29 (2.27%)

11:27
06/23/18
06/23
11:27
06/23/18
11:27
Periodicals
Adding Walgreens to Dow may be wrong move, Barron's says »

The guardians of Dow…

WBA

Walgreens Boots Alliance

$67.60

-0.2 (-0.29%)

GE

General Electric

$13.05

0.29 (2.27%)

FB

Facebook

$201.39

-0.07 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

, C

Citi

$67.20

-0.43 (-0.64%)

11:04
06/23/18
06/23
11:04
06/23/18
11:04
Periodicals
Banks to get green light to increase dividends, share repurchases, Barron's says »

Big banks are expected to…

JPM

JPMorgan

$105.73

-1.79 (-1.66%)

C

Citi

$67.20

-0.43 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 26

    Jul

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

MD

Mednax

$44.99

-0.11 (-0.24%)

10:59
06/23/18
06/23
10:59
06/23/18
10:59
Periodicals
Mednax shares may be at risk amid hospital fights, Barron's says »

After peaking in 2015,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

10:25
06/23/18
06/23
10:25
06/23/18
10:25
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

TWTR

Twitter

$45.90

0.68 (1.50%)

, FOXA

21st Century Fox

$48.59

0.25 (0.52%)

10:21
06/23/18
06/23
10:21
06/23/18
10:21
Periodicals
Biggest winner of World Cup could be Twitter, Barron's says »

Twitter's (TWTR)…

TWTR

Twitter

$45.90

0.68 (1.50%)

FOXA

21st Century Fox

$48.59

0.25 (0.52%)

AMZN

Amazon.com

$1,715.07

-15.13 (-0.87%)

FB

Facebook

$201.39

-0.07 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

AAPL

Apple

$184.85

-0.63 (-0.34%)

, DDAIF

Daimler AG

$0.00

(0.00%)

10:10
06/23/18
06/23
10:10
06/23/18
10:10
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$184.85

-0.63 (-0.34%)

DDAIF

Daimler AG

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

VLKAY

Volkswagen

$0.00

(0.00%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

STMP

Stamps.com

$252.60

0.65 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

A

Agilent

$62.79

-0.24 (-0.38%)

, ABT

Abbott

$61.93

0.19 (0.31%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
American Diabetes Association to hold a conference »

78th Scientific Sessions…

A

Agilent

$62.79

-0.24 (-0.38%)

ABT

Abbott

$61.93

0.19 (0.31%)

AKCA

Akcea Therapeutics

$26.24

0.4 (1.55%)

AMGN

Amgen

$184.86

-1.14 (-0.61%)

AZN

AstraZeneca

$35.06

-0.095 (-0.27%)

BAYRY

Bayer

$0.00

(0.00%)

CL

Colgate-Palmolive

$64.63

1.15 (1.81%)

DXCM

DexCom

$99.52

-0.2 (-0.20%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

IRWD

Ironwood

$19.35

0.74 (3.98%)

JNJ

Johnson & Johnson

$122.81

1.36 (1.12%)

MDT

Medtronic

$86.80

0.51 (0.59%)

MNKD

MannKind

$1.98

0.02 (1.02%)

WAKE

Wake Forest Bancshares Inc.

$0.00

(0.00%)

VLRX

Valeritas

$1.39

0.035 (2.58%)

TNDM

TNDM

SNY

Sanofi

$39.98

0.96 (2.46%)

SIEGY

Siemens

$0.00

(0.00%)

SENS

Senseonics

$4.76

-0.2 (-4.03%)

REGN

Regeneron

$331.82

2.81 (0.85%)

PODD

Insulet

$97.37

0.5697 (0.59%)

NVO

Novo Nordisk

$46.84

0.435 (0.94%)

MRK

Merck

$61.46

0.295 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 28

    Jun

  • 02

    Jul

  • 06

    Jul

  • 12

    Jul

  • 17

    Jul

  • 18

    Jul

  • 11

    Aug

  • 27

    Aug

  • 30

    Aug

  • 10

    Sep

  • 06

    Oct

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Jan

  • 22

    Mar

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 30

    Jun

  • 30

    Jun

ICE

IntercontinentalExchange

$74.81

-0.11 (-0.15%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
IntercontinentalExchange management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

AMGN

Amgen

$184.86

-1.14 (-0.61%)

, ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

04:55
06/23/18
06/23
04:55
06/23/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO World Congress on…

AMGN

Amgen

$184.86

-1.14 (-0.61%)

ARRY

Array BioPharma

$19.37

-0.19 (-0.97%)

BAYRY

Bayer

$0.00

(0.00%)

HALO

Halozyme

$18.07

-0.52 (-2.80%)

INCY

Incyte

$74.02

1.55 (2.14%)

LLY

Eli Lilly

$85.90

-0.17 (-0.20%)

MRK

Merck

$61.46

0.295 (0.48%)

SHPG

Shire

$161.73

-0.7 (-0.43%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$39.98

0.96 (2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

  • 28

    Jun

  • 30

    Jun

  • 30

    Jun

  • 10

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 21

    Dec

  • 28

    Jan

  • 22

    Mar

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

, PCG

PG&E

$42.98

2.44 (6.02%)

18:17
06/22/18
06/22
18:17
06/22/18
18:17
Hot Stocks
Northwest Natural to sell Gill Ranch Storage to SENSA Holdings »

NW Natural (NWN)…

NWN

Northwest Natural Gas

$62.63

0.075 (0.12%)

PCG

PG&E

$42.98

2.44 (6.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

ORLY

O'Reilly Automotive

$285.90

-1.18 (-0.41%)

18:03
06/22/18
06/22
18:03
06/22/18
18:03
Hot Stocks
O'Reilly Automotive's O'Reilly sells 19,250 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJI

South Jersey Industries

$33.15

0.02 (0.06%)

17:46
06/22/18
06/22
17:46
06/22/18
17:46
Hot Stocks
South Jersey Industries announces approval of Elizabethtown Gas purchase »

South Jersey Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAAS

AquaVenture

$15.36

0.12 (0.79%)

17:27
06/22/18
06/22
17:27
06/22/18
17:27
Hot Stocks
AquaVenture extends long-stop date for Ghana plant acquisition to September 30 »

AquaVenture announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Periodicals
Nissan chooses Thailand for hybrid's first export market, Nikkei reports »

Nissan has planned to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROV

Trovagene

$0.81

-0.0068 (-0.83%)

17:22
06/22/18
06/22
17:22
06/22/18
17:22
Hot Stocks
Trovagene CEO William Welch resigns, Dr. Thomas Adams named interim CEO »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$3.26

0.005 (0.15%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$33.49

-0.15 (-0.45%)

17:19
06/22/18
06/22
17:19
06/22/18
17:19
Hot Stocks
Aecom to compete for $148.5M U.S. Army contract »

AECOM-Baker JV, Bryan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:17
06/22/18
06/22
17:17
06/22/18
17:17
Hot Stocks
Lockheed Martin awarded $175.3M U.S. Navy contract modification »

Lockheed Martin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LMT

Lockheed Martin

$298.95

-1.39 (-0.46%)

17:16
06/22/18
06/22
17:16
06/22/18
17:16
Hot Stocks
Lockheed Martin awarded $1.12B U.S. Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

XLE

Energy Select Sector SPDR

$75.21

1.59 (2.16%)

, XLU

Utilities SPDR

$50.75

0.36 (0.71%)

17:14
06/22/18
06/22
17:14
06/22/18
17:14
General news
Week ending ETF Scorecard: Utilities and Real Estate advance, Industrials slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.21

1.59 (2.16%)

XLU

Utilities SPDR

$50.75

0.36 (0.71%)

IYR

DJ US Real Estate Index Fund

$80.69

0.56 (0.70%)

XLP

Consumer Staples Sector SPDR

$51.62

0.42 (0.82%)

XLY

Consumer Discretionary Sector SPDR

$111.34

-0.15 (-0.13%)

XLB

S&P Select Materials SPDR

$58.49

0.79 (1.37%)

XLF

Financial Select Sector

$27.07

-0.145 (-0.53%)

XLV

Health Care Select Sector SPDR

$84.91

0.35 (0.41%)

XLK

Technology Select Sector SPDR

$70.78

-0.24 (-0.34%)

XLI

Industrial Select Sector SPDR

$72.59

0.22 (0.30%)

GLD

SPDR Gold Trust

$120.33

0.27 (0.22%)

SLV

iShares Silver Trust

$15.49

0.135 (0.88%)

USO

United States Oil Fund

$14.02

0.71 (5.33%)

UNG

United States Natural Gas Fund

$23.87

-0.24 (-1.00%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.91

-0.015 (-0.02%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$113.99

0.105 (0.09%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.57

0.06 (0.05%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.11

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.30

0.005 (0.01%)

IWD

iShares Russell 1000 Value

$122.51

0.56 (0.46%)

IWF

iShares Russell 1000 Growth

$146.24

-0.2 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFNX

Pfenex

$5.43

0.14 (2.65%)

17:01
06/22/18
06/22
17:01
06/22/18
17:01
Hot Stocks
Pfenex set to join Russell 2000 Index »

Pfenex announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXE

Bellatrix Exploration

$1.00

-0.0101 (-1.00%)

17:01
06/22/18
06/22
17:01
06/22/18
17:01
Syndicate
Breaking Syndicate news story on Bellatrix Exploration »

Bellatrix Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.